Form D — TUNDRA TARGETED THERAPEUTICS, INC.
0000892712-25-000073 · filed 2025-06-03
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $3,000,000
- Total sold
- $443,500
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- TUNDRA TARGETED THERAPEUTICS, INC.
- CIK
- 2070659
- Entity
- Corporation
- Jurisdiction
- WISCONSIN
- Year incorporated
- 2021
- Address
- 503 S PROSPECT AVE
MADISON, WI 53711 - Phone
- 608-333-1505
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
JEDIAH WILDER WHITE · Executive OfficerMADISON, WI Find on LinkedIn ↗
-
JEFFREY ARNOLD MEDIN · Executive OfficerMADISON, WI Find on LinkedIn ↗
-
BRIAN OLSON · Executive OfficerMADISON, WI Find on LinkedIn ↗
-
JAMES CARAGHER · Executive OfficerMADISON, WI Find on LinkedIn ↗
View original on SEC EDGAR.